Raymond F. Brown

Eli Lilly (United States)

Publishes on Antibiotic Resistance in Bacteria, Protein Kinase Regulation and GTPase Signaling, Synthesis of β-Lactam Compounds. 16 papers and 4.1k citations.

PubIndex Score3Top 97% · seniorHow it's scored

16Publications

4.1kTotal Citations

First publication: 1946First senior author: 1946

Antibiotic Resistance in Bacteria Protein Kinase Regulation and GTPase Signaling Synthesis of β-Lactam Compounds Synthesis and Characterization of Heterocyclic Compounds Immune Response and Inflammation

Top publicationsby citations

A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002).

Chris J. Vlahos, Raymond F. Brown, William F. Matter et al.|Journal of Biological Chemistry|1994

Cited by 3.3k

The inhibition of phosphatidylinositol 3-kinase by quercetin and analogs

William F. Matter, Chris J. Vlahos, Raymond F. Brown|Biochemical and Biophysical Research Communications|1992

Cited by 198

Investigation of neutrophil signal transduction using a specific inhibitor of phosphatidylinositol 3-kinase.

Chris J. Vlahos, William F. Matter, Raymond F. Brown et al.|The Journal of Immunology|1995

Cited by 174

Antagonists of Phosphatidylinositol 3-Kinase Block Activation of Several Novel Protein Kinases in Neutrophils

Jiabing Ding, John A. Badweyt, Chris J. Vlahos et al.|Journal of Biological Chemistry|1995

Cited by 125

Losartan, a nonpeptide angiotensin II (Ang II) receptor antagonist, inhibits neointima formation following balloon injury to rat carotid arteries

Raymond F. Kauffman, Mitchell I. Steinberg, James S. Bean et al.|Life Sciences|1991

Cited by 122